Drugs / NT-020
NT-020
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01963767 | May 2011 → Feb 2013 | premature aging syndrome | University of South Florida | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NT-020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01963767 ↗ |
| Known as | Natura Therapeutics Nutrastem | “either NT-020 (Natura Therapeutics Nutrastem) or matching placebo” NCT01963767 ↗ |
| Known as | NutraStem | “Recommended intake of NT-020 (NutraStem®) is two (2) capsules daily.” NCT01963767 ↗ |
| Modality | Other / unclassified | “the nutraceutical NT-020” NCT01963767 ↗ |